氯雷他定片聯(lián)合甘草鋅顆粒治療慢性蕁麻疹的效果

打開文本圖片集

[摘 要]目的 分析氯雷他定片聯(lián)合甘草鋅顆粒對慢性蕁麻疹患者的影響。方法 選取我院2020年1月-2022年12月收治的82例慢性蕁麻疹患者為研究對象，采用隨機(jī)數(shù)字表法分為對照組與觀察組，每組41例。對照組給予氯雷他定片，觀察組給予氯雷他定片聯(lián)合甘草鋅顆粒，比較兩組血清炎癥指標(biāo)及癥狀評分。結(jié)果 兩組治療后血清TNF-α、IgE、IL-4、IL-10和hs-CRP水平均低于治療前，且觀察組低于對照組（P

[關(guān)鍵詞] 氯雷他定片；甘草鋅顆粒；慢性蕁麻疹

[中圖分類號] R758.24； R287 [文獻(xiàn)標(biāo)識碼] A [文章編號] 1004-4949（2024）02-0068-03

Effect of Loratadine Tablets Combined with Licorzinc Granules in the Treatment of Chronic Urticaria

YANG Zhan-feng

（Department of Dermatology， Gaoyisheng Aesthetic Medical Hospital， Xi’an 710000， Shaanxi， China）

[Abstract]Objective To analyze the effects of loratadine tablets combined with licorzinc granules on patients with chronic urticaria. Methods A total of 82 patients with chronic urticaria admitted to our hospital from January 2020 to December 2022 were selected as the research objects. They were divided into control group and observation group by random number table method， with 41 patients in each group. The control group was given loratadine tablets， and the observation group was given loratadine tablets combined with licorzinc granules. The serum inflammatory indexes and symptom scores of the two groups were compared. Results After treatment， the levels of serum TNF-α， IgE， IL-4， IL-10 and hs-CRP in the two groups were lower than those before treatment， and those in the observation group were lower than those in the control group （P

[Key words] Loratadine tablets； Licorzinc granules； Chronic urticaria

慢性蕁麻疹（chronic urticaria）表現(xiàn)為患者皮膚表面大小形狀不一且數(shù)目較多風(fēng)團(tuán)，常伴有瘙癢癥狀[1]。（剩余3639字）